Journal of Multiple Sclerosis and Neuroimmunology

Hashimoto’s Encephalopathy Presenting as Dizziness and Diplopia: Ga Eun Koo, Yi Seul Choo, Hae-Won Shin; J Mult Scler Neuroimmunol. 2023;14(2):122-124. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.122; Full text PubReader ePub PDF

Rituximab Treatment for Neuroimmunologic Disorders: Ilhan Yoo; J Mult Scler Neuroimmunol. 2023;14(1):44-50. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.44; Full text PubReader ePub PDF

New Therapeutic Agents in Myasthenia Gravis: Jinhee Kim, Ha Young Shin; J Mult Scler Neuroimmunol. 2023;14(1):34-43. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.34; Full text PubReader ePub PDF

The Role of T Cell Tolerance in the Pathogenesis and Treatment of Autoimmune Diseases: Kyungho Choi; J Mult Scler Neuroimmunol. 2013;4(1):13-18. Published online March 1, 2013; PDF

The Prospective Nation-wide Multiple Sclerosis Registry: Interim Analysis of Clinical Data: Ohyun Kwon, Ho Jin Kim, Byung-Joon Kim, Min Su Park, Byung-Jo Kim, Joo-Hong Min, Kwang-Soo Lee, Jae-Young An, Kwang-Kuk Kim, Young-Min Lim, Sang-Myung Cheon, Seung Min Kim, Sang-Soo Lee, Yoon-Ho Hong, Sun-Young Kim, Man-Seok Park, Byoung-Soo Shin, Jong-Seok Bae, Jong-Kuk Kim, Kwang Ho Lee; J Mult Scler Neuroimmunol. 2010;1(2):52-58. Published online September 1, 2010; PDF

4,834	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
1,436	Rituximab Treatment for Neuroimmunologic Disorders
1,320	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
1,128	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
1,020	New Therapeutic Agents in Myasthenia Gravis

Search